Man Group
CRL icon

Man Group’s Charles River Laboratories CRL Stock Holding History

Man Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,457
Closed -$1.89M – 2424
2025
Q4 		$1.89M Sell
9,457
-91,103
-91% -$16.5M ﹤0.01% 1466
2025
Q3 		$15.7M Sell
100,560
-47,900
-32% -$7.61M 0.03% 591
2025
Q2 		$22.5M Buy
148,460
+27,408
+23% +$3.65M 0.04% 463
2025
Q1 		$18.2M Buy
121,052
+38,662
+47% +$6.48M 0.05% 478
2024
Q4 		$15.2M Buy
82,390
+64,456
+359% +$12.4M 0.04% 550
2024
Q3 		$3.53M Buy
17,934
+5,601
+45% +$1.16M 0.01% 1143
2024
Q2 		$2.55M Buy
+12,333
New +$2.79M 0.01% 1271
2022
Q2 		– Sell
-26,613
Closed -$6.5M – 472
2022
Q1 		$7.56M Buy
26,613
+19,383
+268% +$5.98M 0.03% 726
2021
Q4 		$2.72M Sell
7,230
-6,818
-49% -$2.65M 0.01% 1086
2021
Q3 		$5.8M Sell
14,048
-29,531
-68% -$12.3M 0.02% 780
2021
Q2 		$16.1M Buy
43,579
+20,090
+86% +$6.71M 0.06% 384
2021
Q1 		$6.81M Sell
23,489
-33,202
-59% -$9.23M 0.03% 572
2020
Q4 		$14.2M Buy
56,691
+30,249
+114% +$7.2M 0.06% 320
2020
Q3 		$5.99M Buy
26,442
+19,431
+277% +$4.03M 0.02% 716
2020
Q2 		$1.22M Sell
7,011
-34,186
-83% -$5.46M 0.01% 1215
2020
Q1 		$5.2M Sell
41,197
-48,594
-54% -$7.29M 0.03% 478
2019
Q4 		$13.7M Buy
89,791
+65,385
+268% +$9.05M 0.05% 518
2019
Q3 		$3.23M Sell
24,406
-25,561
-51% -$3.43M 0.01% 1074
2019
Q2 		$7.09M Sell
49,967
-47,889
-49% -$6.5M 0.03% 804
2019
Q1 		$14.2M Buy
97,856
+44,645
+84% +$5.87M 0.05% 430
2018
Q4 		$6.02M Sell
53,211
-35,259
-40% -$4.41M 0.03% 678
2018
Q3 		$11.9M Buy
88,470
+16,952
+24% +$2.09M 0.04% 530
2018
Q2 		$8.03M Buy
71,518
+41,776
+140% +$4.52M 0.03% 697
2018
Q1 		$3.17M Buy
+29,742
New +$3.21M 0.01% 1086

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Man Group's CRL Position: Q1 2026 in Review

Man Group sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 9,457 shares — an estimated $1.89M sold.

Man Group first reported a position in CRL in Q1 2018 and held it in 24 quarters. The position peaked at $22.5M in Q2 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Man Group reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 9,457 Charles River Laboratories shares in Q1 2026, an estimated $1.89M.
  • Man Group first reported a position in Charles River Laboratories in Q1 2018 and held it in 24 quarters.
  • Man Group's Charles River Laboratories position peaked at $22.5M in Q2 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.